WPD Pharmaceuticals Stock (OTCMKTS:WCOTF)

USA |OTCMKTS |USD

Price
$ -
Change
-
Today's Range
$ - - $ -
52-Week Range
$ 0.17 - $ 0.33
Market Cap
$ 10.08M
Volume
-

About Wpd Pharmaceuticals (OTCMKTS:WCOTF)

(OTCMKTS:WCOTF) WPD Pharmaceuticals Inc. engages in the research and development of medicinal products in the fields of oncology and infectious disease. Its drug development pipeline includes WPD101 to treat brain cancers, including glioblastoma that is in the pre-clinical trial; WPD102 to treat Uval Melanoma, which is in the pre-clinical trial; Berubicin for the treatment of glioblastoma that us in phase 1 clinical trial; and WP1066 to treat CNS tumors, pancreatic cancer, and ocular tumors, which is in phase 1 clinical trial. The company's drug development pipeline also includes WP1732 for the treatment of pancreatic cancer; WP1220 to treat cutaneous T-cell lymphoma; WPD103 for the treatment of GBM, melanoma, and other cancers that is in the pre-clinical trial; and Annamycin to treat AML and metastasis to lungs, which is in Phase I/II clinical trials in AML. WPD Pharmaceuticals Inc. is based in Vancouver, Canada.
Show more

WCOTF Stock Price

Chart by TradingView

Statistics Highlights (OTCMKTS:WCOTF)

Shares Outstanding - Beta -
Public Float - P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 52.24% Ex-Dividend Date
Held by Institutions - IPO Date -
Explore More on "Statistics" Section

WCOTF Financial Summary

|
Jan 20 Jan 19 Jan 18
Revenue $0.00 $0.00 $0.00
EBITDA $ $ $
Net Income $-11.61M $-779.44K $-423.38K
Total Assets $4.07M $3.93M $408.12K
Total Cash $2.95M $801.06K $195.51K
Total Debt $ $0.00 $0.00
Jul 20 Apr 20 Jan 20
Revenue $0.00 $0.00 $0.00
EBITDA $ $ $
Net Income $-1.26M $-2.25M $-2.24M
Total Assets $4.20M $3.51M $3.98M
Total Cash $2.70M $1.99M $2.04M
Total Debt $ $ $

(OTCMKTS:WCOTF) Stock Price FAQs

What is Wpd Pharmaceuticals's 52-week change?

Wpd Pharmaceuticals (OTCMKTS:WCOTF) FAQ

How Much is Wpd pharmaceuticals Worth?

Wpd pharmaceuticals's worth today based on market capitalisation is $10.08M

How much dividend does Wpd pharmaceuticals Pay?

The current annualized dividend payout for WCOTF stock is $0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Wpd pharmaceuticals's "Dividend" Section

What is Wpd pharmaceuticals’s Price to Earning (PE) ratio?

WCOTF stock also has a Price to Sales (P/S) ratio of 0.00.

What is the Wpd pharmaceuticals's ticker?

Wpd pharmaceuticals trades on the OTC Markets stock market in USA under the ticker symbol "WCOTF". Wpd pharmaceuticals’s stock symbol can also be displayed as "OTCMKTS:WCOTF".

Who are the owners of Wpd pharmaceuticals?

Wpd pharmaceuticals (OTCMKTS:WCOTF) is owned by 0.00% institutional shareholders and by 52.24% insiders. The rest is owned by the public.
Explore More Details on Wpd pharmaceuticals's “Ownership” Section

Who are the key executives of Wpd pharmaceuticals (WCOTF)?

Wpd pharmaceuticals's key executive team includes the following managers:

  • Mr. Mariusz Olejniczak, CEO & Director (NA)
  • Dr. Waldemar Priebe Ph.D., Founder & Chairman of Scientific Advisory Board (NA)
  • Mr. Christopher P. Cherry C.A., CPA, CPA, CA, CGA, CFO & Director (1979)
  • Ms. Beata Pajak, Chief Scientific Officer & Director (NA)

What is Wpd pharmaceuticals’s Sector & Industry Classification?

Wpd pharmaceuticals (OTCMKTS:WCOTF) is classified under the "" sector and under the "" industry.

How many employees work for Wpd pharmaceuticals?

Currently the number of employees working for Wpd pharmaceuticals is 0.

What are Wpd pharmaceuticals's Address and Phone Number?

Wpd pharmaceuticals’s mailing address is Zwirki i Wigury 101, Warsaw, Poland, 02-089.
The company’s phone number is 48 515 26 23 81.

What is the official website for Wpd pharmaceuticals?

Wpd pharmaceuticals’s official website is http://www.wpdpharmaceuticals.com